THE EVALUATION OF COGNITIVE SKILLS AND THE QUALITY OF LIFE BETWEEN PARKINSON DISEASE PATIENTS AND HEALTHY AGED PEOPLE ABOVE 60 YEARS OLD
In the 21st century mankind has made a huge progress in the health care system, so the average life expectancy has increased signiёcantly compared to the previous centuries. The managing of healthy ageing of the population represents one of the main actual problems of the national health care systems around the world as the aged population is increasing, so, for instance, it is estimated that there will be over 2 billion people worldwide over the age of 65 by the year 2050 [36]. In particular, the age-related neurological diseases such as Parkinson Disease (PD) have seen a dramatic increase in international prevalence. Projections suggest that the neurodegenerative diseases like PD will surpass cancer as the leading cause of death by the year 2040 [36]; thus presenting an ever-growing challenge to maintain an optimal quality of life of the patients. In healthy ageing, cognitive skills impair naturally due to natural brain atrophy; in PD these processes are rather accelerated, so that, overwhelming clinical studies showed that dementia eventually develops in up to 80–85% of patients with PD [1, 39]. This article is focuses on evaluating the health related quality of life measurements of PD patients such as cognitive status, anxiety and stress levels as well as it aims to suggest a possible future strategy to improve the quality of life of the patients.
Авторы
Тэги
Тематические рубрики
Предметные рубрики
В этом же номере:
Резюме по документу**
P. 741–748
A. A. Akanova1, 2, S. U. Kamenova1, A. K. Yeshmanova2, A. G. Beltenova1, 2, A. M. Kondybayeva1
THE EVALUATION OF COGNITIVE SKILLS AND THE QUALITY OF LIFE
BETWEEN PARKINSON DISEASE PATIENTS
AND HEALTHY AGED PEOPLE ABOVE 60 YEARS OLD
1 S. D. Asfendiayrov Kazakh National Medical University, 94, ul. <...> In particular, the age-related neurological
diseases such as Parkinson Disease (PD) have seen
a dramatic increase in international prevalence. <...> Projections suggest that the neurodegenerative
diseases like PD will surpass cancer as the leading
cause of death by the year 2040 [36]; thus presenting an
ever-growing challenge to maintain an optimal quality
of life of the patients. <...> In healthy ageing, cognitive
skills impair naturally due to natural brain atrophy; in
PD these processes are rather accelerated, so that,
overwhelming clinical studies showed that dementia
eventually develops in up to 80–85 % of patients
with PD [1, 39]. <...> This article is focuses on evaluating
the health related quality of life measurements of PD
patients such as cognitive status, anxiety and stress
levels as well as it aims to suggest a possible future
strategy to improve the quality of life of the patients. <...> In particular, the age-related neurological
diseases such as Parkinson Disease (PD) have
seen a dramatic increase in international prevalence. <...> Projections suggest that the neurodegenerative diseases
like PD will surpass cancer as the leading cause of
death by the year 2040 [36]; Parkinson’s disease is an
age-associated progressive neurodegenerative disorder
characterized by degeneration of dopaminergic
neurons in the brain, and affects 1 % of the population
over 60 years old [61]. <...> PD was
thought to be an exceptionally motor disorder, but
the latest research showed that there are also nonmotor
symptoms [10, 12, 32]. <...> Approximately 25 %
of cognitively intact patients with Parkinson’s disease
meet neuropsychological test criteria for mild cognitive
impairment (MCI) [2, 27] and most of them develop
dementia as the disease progresses [1, 31]. <...> MCI is an
intermediate stage between normal ageing and dementia
that was initially conceptualized as a prodrome of severe
dementia. <...> Unfortunately,
there is no well-understood biochemical or anatomical <...>
** - вычисляется автоматически, возможны погрешности
Похожие документы: